These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 12716753)
1. A low-iron-available, polyphenol-enriched, carbohydrate-restricted diet to slow progression of diabetic nephropathy. Facchini FS; Saylor KL Diabetes; 2003 May; 52(5):1204-9. PubMed ID: 12716753 [TBL] [Abstract][Full Text] [Related]
2. Treatment of diabetic nephropathy with angiotensin II receptor antagonist. Lewis EJ; Lewis JB Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737 [TBL] [Abstract][Full Text] [Related]
3. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial). Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260 [TBL] [Abstract][Full Text] [Related]
4. Diabetic nephropathy: how effective is treatment in clinical practice? Joss N; Paterson KR; Deighan CJ; Simpson K; Boulton-Jones JM QJM; 2002 Jan; 95(1):41-9. PubMed ID: 11834772 [TBL] [Abstract][Full Text] [Related]
5. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Pedrini MT; Levey AS; Lau J; Chalmers TC; Wang PH Ann Intern Med; 1996 Apr; 124(7):627-32. PubMed ID: 8607590 [TBL] [Abstract][Full Text] [Related]
6. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Meloni C; Tatangelo P; Cipriani S; Rossi V; Suraci C; Tozzo C; Rossini B; Cecilia A; Di Franco D; Straccialano E; Casciani CU J Ren Nutr; 2004 Oct; 14(4):208-13. PubMed ID: 15483780 [TBL] [Abstract][Full Text] [Related]
7. Protein restriction for diabetic renal disease. Waugh NR; Robertson AM Cochrane Database Syst Rev; 2000; (2):CD002181. PubMed ID: 10796869 [TBL] [Abstract][Full Text] [Related]
8. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. Brenner BM; Cooper ME; de Zeeuw D; Keane WF; Mitch WE; Parving HH; Remuzzi G; Snapinn SM; Zhang Z; Shahinfar S; N Engl J Med; 2001 Sep; 345(12):861-9. PubMed ID: 11565518 [TBL] [Abstract][Full Text] [Related]
9. [The role of the diet as a risk factor for the development and progression of diabetic nephropathy]. Mello VD; Azevedo MJ; Zelmanovitz T; Gross JL Arq Bras Endocrinol Metabol; 2005 Aug; 49(4):485-94. PubMed ID: 16358075 [TBL] [Abstract][Full Text] [Related]
10. Reduced albuminuria after dietary protein restriction in insulin-dependent diabetic patients with clinical nephropathy. Ciavarella A; Di Mizio G; Stefoni S; Borgnino LC; Vannini P Diabetes Care; 1987; 10(4):407-13. PubMed ID: 3622197 [TBL] [Abstract][Full Text] [Related]
11. Diabetic nephropathy--the family physician's role. Roett MA; Liegl S; Jabbarpour Y Am Fam Physician; 2012 May; 85(9):883-9. PubMed ID: 22612183 [TBL] [Abstract][Full Text] [Related]
12. Factors affecting progression of renal failure in patients with type 2 diabetes. Ueda H; Ishimura E; Shoji T; Emoto M; Morioka T; Matsumoto N; Fukumoto S; Miki T; Inaba M; Nishizawa Y Diabetes Care; 2003 May; 26(5):1530-4. PubMed ID: 12716817 [TBL] [Abstract][Full Text] [Related]
13. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial. Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF; Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258 [TBL] [Abstract][Full Text] [Related]
14. Renal protection in diabetes--an emerging role for calcium antagonists. Parving HH; Tarnow L; Rossing P Cardiology; 1997; 88 Suppl 3():56-62. PubMed ID: 9397296 [TBL] [Abstract][Full Text] [Related]
15. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Keane WF; Brenner BM; de Zeeuw D; Grunfeld JP; McGill J; Mitch WE; Ribeiro AB; Shahinfar S; Simpson RL; Snapinn SM; Toto R; Kidney Int; 2003 Apr; 63(4):1499-507. PubMed ID: 12631367 [TBL] [Abstract][Full Text] [Related]
16. Severe dietary protein restriction in overt diabetic nephropathy: benefits or risks? Meloni C; Morosetti M; Suraci C; Pennafina MG; Tozzo C; Taccone-Gallucci M; Casciani CU J Ren Nutr; 2002 Apr; 12(2):96-101. PubMed ID: 11953922 [TBL] [Abstract][Full Text] [Related]
17. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM; Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578 [TBL] [Abstract][Full Text] [Related]
18. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245 [TBL] [Abstract][Full Text] [Related]
19. [Risk and prevention of diabetic nephropathy]. Ravera M; Re M; Deferrari G G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442 [TBL] [Abstract][Full Text] [Related]
20. Pancreas transplantation for the prevention of diabetic nephropathy. Stegall MD; Larson TS; Kudva YC; Grande JP; Nyberg SL; Prieto M; Velosa JA; Rizza RA Mayo Clin Proc; 2000 Jan; 75(1):49-56. PubMed ID: 10630757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]